IQVIA
Lewis Atkinson (M.APS) is an experienced business development leader in the life sciences sector, currently serving as the Director of Business Development for PV Drug Safety Technology at IQVIA since June 2020. In this role, Lewis drives business development for Global PV Tech Solutions across Europe, focusing on drug safety compliance and collaborating with Pharma and Biotech clients in the EMEA region to optimize adverse event case processing. Prior to this, Lewis held various leadership positions in strategic business development at Ideagen Plc and as Head of Business Development for Morgan Kai Limited, where responsibilities included spearheading business development activities across the Gulf Middle East region and the Central & Local Government sector in Europe. Additional experience includes serving as Head of International at Prospect Health, where Lewis successfully managed the international division and drove strategy for market share growth. Lewis holds a GNVQ Advanced Business Studies Level 3 from Harrogate College.
This person is not in any teams
This person is not in any offices
IQVIA
163 followers
IQVIA, formerly Quintiles IMS Holdings, Inc., is an American multinational company serving the combined industries of health information technologies and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.